News – Page 417 – Endpoints News

US set to pay nearly $2B for Pfizer's Covid-19 treatment Paxlovid in 2023

3 years ago

Catalent to build a $40M analytical services facility in North Carolina's Research Triangle

3 years ago

Aligning drug prices with ICER estimates could save tens of billions of dollars — JAMA paper

3 years ago

Vanda loses Hetlioz patent court decision, vows to appeal and ask for stay on Teva, Apotex competitors

3 years ago

Novartis offloads five eye drugs in deal worth up to $175M

3 years ago

With new CEO, Passage Bio gives early look at first six patients in GM1 gangliosidosis gene therapy trial

3 years ago

Avidity touts early data, showing positive effect on progressive muscular disease while under partial FDA hold

3 years ago

Icosavax pushes forward with an RSV candidate after Covid-19 vaccine flop

3 years ago

Prothena hopes to raise $180M after Eisai Alzheimer's data prompted stock surge

3 years ago

And then there were 8: Fresenius nabs the latest Humira biosimilar approval

3 years ago

After #ASH22: Post-mortem analysis on biggest Twitter buzz around drugs, studies and biopharmas

3 years ago

Say goodbye to Vallon as a low-profile NKT cell startup steps into its battered shoes on Nasdaq

3 years ago

Targeted radiotherapy biotech out of Longitude Capital raises a fresh $75M

3 years ago

Kymera and Sanofi move ahead with skin drug after promising PhI data

3 years ago

Corrected: AbbVie, Ipsen end partnerships with Exicure following setbacks, job cuts

3 years ago

FDA adcomm votes 8-3 against Cytokinetics' potential heart failure drug

3 years ago

Pfizer projects mRNA vaccine sales will hover around $15B by 2030

3 years ago

Eli Lilly anticipates revenue boost in 2023 as it prepares to launch slate of new drugs

3 years ago

Indonesia's state-owned pharma company strikes deal to manufacture Merck’s HPV vaccine

3 years ago

Novo Nordisk addresses off-label Ozempic use as it grapples with multiple shortages

3 years ago

Short-term government spending bill includes reauthorizations of orphan drug credits and other pharma perks

3 years ago

Pfizer's plan for $110+ Covid-19 vaccines riles up US senators

3 years ago

Roche wins earlier-than-expected approval for blockbuster Tecentriq in rare soft tissue cancer

3 years ago

In its largest single-asset purchase ever, Takeda snaps up TYK2 drug for $4B upfront

3 years ago

First page Previous page 414 415 416417418 419 420 Next page Last page